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Abstract
The second messenger, cyclic diguanylate (c-di-GMP), regulates diverse cellular processes in bacteria. C-di-GMP is produced
by diguanylate cyclases (DGCs), degraded by phosphodiesterases (PDEs), and receptors couple c-di-GMP production to
cellular responses. In many bacteria, including Vibrio cholerae, multiple DGCs and PDEs contribute to c-di-GMP signaling,
and it is currently unclear whether the compartmentalization of c-di-GMP signaling components is required to mediate c-di-
GMP signal transduction. In this study we show that the transcriptional regulator, VpsT, requires c-di-GMP binding for
subcellular localization and activity. Only the additive deletion of five DGCs markedly decreases the localization of VpsT,
while single deletions of each DGC do not impact VpsT localization. Moreover, mutations in residues required for c-di-GMP
binding, c-di-GMP-stabilized dimerization and DNA binding of VpsT abrogate wild type localization and activity. VpsT does
not co-localize or interact with DGCs suggesting that c-di-GMP from these DGCs diffuses to VpsT, supporting a model in
which c-di-GMP acts at a distance. Furthermore, VpsT localization in a heterologous host, Escherichia coli, requires a
catalytically active DGC and is enhanced by the presence of VpsT-target sequences. Our data show that c-di-GMP signaling
can be executed through an additive cellular c-di-GMP level from multiple DGCs affecting the localization and activity of a c-
di-GMP receptor and furthers our understanding of the mechanisms of second messenger signaling.
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Introduction
Second messengers are small diffusible signaling molecules that
are produced or degraded in response to external stimuli and relay
information to a receptor to elicit a specific cellular response [1].
The cyclic nucleotide cyclic diguanylate (c-di-GMP) is a bacterial
second messenger that controls the transition between a free living
and biofilm lifestyle [2,3]. C-di-GMP is produced by diguanylate
cyclases (DGCs), containing GGDEF domains, and degraded by
phosphodiesterases (PDEs), containing EAL or HD-GYP domains.
Cellular c-di-GMP is sensed by receptors that interact with
downstream targets to affect cellular functions. C-di-GMP
signaling often involves numerous GGDEF, EAL or HD-GYP
domain containing proteins and receptors [4], and previous
reports suggest that the compartmentalization of c-di-GMP
signaling components could facilitate the activation of specific
cellular processes [3,5,6]. However, it is currently unclear whether
compartmentalization is required to mediate c-di-GMP signal
transduction in bacteria.
Recent advances in the identification of c-di-GMP receptors
have helped define the mechanisms by which c-di-GMP mediates
downstream processes. These receptors include riboswitches [7]
and proteins that contain various binding domains. PilZ domains
are known to bind c-di-GMP and proteins harboring these
domains modulate cellular processes such as motility through
protein-protein interactions with the flagellar motor complex [8–
10]. Proteins containing degenerate GGDEF or EAL domains,
which have lost their enzymatic activity, are also known to be c-di-
GMP receptor proteins. In Pseudomonas fluorescens, LapD binds c-di-
GMP through a degenerate EAL domain and modulates the cell
surface association of an adhesin through direct interactions with a
periplasmic protease [11–13]. The degenerate GGDEF domain
containing protein CdgG was shown to regulate biofilm formation
in Vibrio cholerae [14]. C-di-GMP can also regulate gene expression
by binding transcriptional regulators such as the Crp homolog Clp
[15] or FleQ [16]. Although the identities of many c-di-GMP
receptor proteins are known, the mechanisms of c-di-GMP-
mediated signal transduction and gene regulation are not fully
understood.
In V. cholerae, the bacterial pathogen that causes the disease
cholera, c-di-GMP regulates biofilm formation, motility and
virulence [17–19]. The V. cholerae genome contains 31 genes
encoding proteins with GGDEF domains, 11 genes encoding
proteins with EAL domains, 10 genes encoding proteins with both
GGDEF and EAL domains and 9 genes encoding proteins with
HD-GYP domains [14,20]. Recently, we characterized VpsT,
which is a key c-di-GMP receptor known to regulate biofilm
formation in V. cholerae [21]. Biofilm formation in V. cholerae
requires the biosynthesis of Vibrio polysaccharide (VPS) [22,23],
and VpsT activates vps expression through direct binding of the
PLoS Pathogens | www.plospathogens.org 1 May 2012 | Volume 8 | Issue 5 | e1002719vpsL promoter [21,24]. VpsT is a novel member of the FixJ, LuxR
and CsgD family of transcriptional regulators that contains a c-di-
GMP binding motif and a 6
th alpha helix at its N-terminal receiver
domain that stabilizes homodimerization [21]. These features
make VpsT unique compared to other response regulators and c-
di-GMP binding proteins.
In this study, we report that VpsT requires c-di-GMP binding
and subcellular localization to regulate gene expression. The wild-
type VpsT localization pattern is dependent on c-di-GMP binding,
c-di-GMP-stabilized dimerization, and the VpsT DNA binding
domain. We also show that VpsT does not co-localize or interact
with DGCs. Instead, multiple DGCs contribute additively to a
cellular c-di-GMP concentration, which affects the localization
and activity of the c-di-GMP receptor protein, VpsT.
Results/Discussion
VpsT Is Subcellularly Localized and Multiple DGCs
Contribute Additively to VpsT Localization
We hypothesized that the c-di-GMP receptor protein, VpsT, is
subcellularly localized, and this localization facilitates c-di-GMP
signal transduction. To determine whether VpsT is subcellularly
localized, we constructed an N-terminal tagged green fluorescent
protein (GFP)-VpsT fusion. Expression of gfp-vpsT recovered vpsL
expression in a DvpsT strain (Figure 1A). vpsL is the first gene in the
vps-II operon and VpsT directly binds to the upstream regulatory
region of this gene [21,22]. Expression of vpsL was similar between
strains expressing gfp-vpsT or vpsT alone indicating that our fusion
protein is functional. When observed by fluorescence microscopy,
GFP-VpsT formed a pattern of localization within the cell
(Figure 1B), while a strain expressing GFP exhibited homogenous
fluorescence throughout the cytoplasm. We confirmed that this
localization was not due to different cellular protein concentra-
tions, as levels of GFP-VpsT were similar to levels of GFP alone
(Figure S1). A census of more than 150 cells per treatment showed
that cells expressing GFP-VpsT contained more spots per cell
when compared to cells expressing GFP alone when quantified
using MicrobeTracker software (Figure 1C) [25]. GFP-VpsT
localization also exhibited a higher ratio of maximum to average
fluorescence intensity across the length of individual cells when
compared to cells expressing GFP alone (Figure S1). These results
indicate that GFP-VpsT is subcellularly localized.
The striking number of GGDEF, EAL and HD-GYP domain
containing proteins present in many bacteria is thought to
generate flexibility in signal transduction, allowing multiple
sensory inputs to be fed through a single diffusible signaling
molecule [4]. Since VpsT is a c-di-GMP binding protein and is
subcellularly localized, we wondered whether specific DGCs or
PDEs are important for this localization pattern. We therefore
measured expression of the vpsL promoter in wild-type V. cholerae
and 52 strains containing in-frame deletions of each gene in the V.
cholerae genome encoding proteins with GGDEF, EAL or GGDEF
and EAL domains. Of the strains examined, 5 DGC deletion
strains showed a 2-fold or greater decrease in expression of vpsL
(Figure 1D and S2), namely the previously characterized genes
encoding DGCs cdgA (VCA0074), cdgH (VC1067), cdgK (VC1104)
and cdgL (VC2285) [14,26,27], and a predicted DGC, VC1376,
which we name here, cdgM. Furthermore, c-di-GMP levels
decreased between 86% and 54% in each single DGC deletion
strain when compared to wild type (Figure 1E). These results show
that multiple DGCs are involved in vps regulation and thus
identified likely candidate DGCs important for VpsT localization.
We then observed VpsT localization in strains lacking each of
the 5 DGCs important for vpsL expression. VpsT localization was
not markedly altered in any strain containing a single DGC
deletion (Figure S1). We then reasoned that VpsT localization may
not be dependent on a single DGC, but instead, multiple DGCs
contribute additively to VpsT localization. Therefore, we created a
strain where all 5 DGCs are deleted in combination, designated
D5DGC. D5DGC exhibited a lower vpsL expression than any
single DGC mutant strain (Figure 1D). Moreover, c-di-GMP levels
were significantly decreased (17%) in the D5DGC strain compared
to wild type (Figure 1E). In the D5DGC strain, GFP-VpsT
localization was reduced and the number of spots per cell and ratio
of maximum to average fluorescence intensity were markedly
lower compared to wild type expressing the same fluorescent
fusion protein (Figure 1B, 1C and S1). This change in GFP-VpsT
localization was not due to different cellular protein concentra-
tions, as GFP-VpsT levels were similar to levels of GFP alone in
the D5DGC strain (Figure S1). These results indicate that no single
DGC is sufficient to cause VpsT mis-localization, and instead,
multiple DGCs additively impact the GFP-VpsT localization
pattern. The number of spots per cell in the D5DGC strain was
not completely diminished, and we speculate that a low level of c-
di-GMP is still present in the cell due to remaining DGCs, which
facilitate VpsT localization. Alternatively, a range of VpsT target
promoters that differ in their affinities for the active regulator
could cause this localization pattern. Above observations of VpsT
localization and activity suggest that VpsT function is dependent
on reaching a critical cellular c-di-GMP threshold. Thus we
wondered whether a single DGC could rescue vpsL expression in
the D5DGC strain. When cdgA was expressed on a plasmid in the
D5DGC mutant, vpsL expression was recovered in the D5DGC
strain when compared to the D5DGC mutant harboring the
vector alone (Figure S3). These results suggest that one DGC can
rescue a cellular level of c-di-GMP for the activation of vpsL
expression in the D5DGC strain.
In our survey of DGC and PDE mutants, we also observed
multiple PDEs to be negative regulators of vps expression (Figure
S2), consistent with previous work [26,28–30]. However, strains
Author Summary
C-di-GMP is a ubiquitous intracellular signaling molecule in
bacteria and controls diverse cellular processes including
biofilm formation, motility and virulence. The genomes of
many bacteria often contain numerous genes encoding
proteins predicted to produce and degrade c-di-GMP.
However, it is currently unclear how a bacterial cell
orchestrates multiple c-di-GMP signaling proteins to elicit
a specific cellular response. The microbial pathogen, Vibrio
cholerae, contains a multitude of c-di-GMP proteins and c-
di-GMP signaling is likely important for the bacterium to
cause the deadly diarrheal disease called cholera. In the
present study, we define the requirements for c-di-GMP
signal transduction in V. cholerae. We identify specific c-di-
GMP proteins that additively stimulate the subcellular
localization and activity of the c-di-GMP binding protein
and transcriptional regulator, VpsT. We further show that
c-di-GMP signaling does not require the interaction of c-di-
GMP signaling components. However, a common cellular
level of c-di-GMP contributes to VpsT localization and
activity. This is the first account of the subcellular
localization of a transcriptional regulator modulated by
c-di-GMP binding. Furthermore, this study establishes that
c-di-GMP signal transduction can act at a distance through
a common cellular level of c-di-GMP and defines how an
intracellular second messenger can regulate cellular
processes in bacteria.
A Mechanism of c-di-GMP Signaling in V. cholerae
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rocS and cdgC individually or in combination, exhibited no
significant alteration in GFP-VpsT localization pattern (Figure
S4). Therefore, an upper c-di-GMP concentration limit may exist,
after which, further VpsT localization is not observable. Alterna-
tively, the experimental system might be saturated, and no further
localization can be observed.
VpsT as a response regulator is not unique in its capacity to
subcellularly localize in response to specific stimuli or modifica-
tion. CsgD from Salmonella enterica was shown to form foci
associated with the membrane in a subpopulation of cells in
response to cell aging [31]. WspR from Pseudomonas aeruginosa was
shown to localize to foci in response to phosphorylation [32].
OmpR from Escherichia coli subcellularly localizes in response to the
presence and activity of its cognate histidine kinase, EnvZ [33].
Whereas typical response regulators, such as OmpR, are activated
by a single major cognate histidine kinase [34], VpsT localization
and activity is modulated in response to c-di-GMP produced by
multiple DGCs. These results are consistent in the context of
second messenger signaling, where multiple independent inputs
can be fed through a single diffusible signaling molecule to elicit a
specific cellular response [1].
VpsT, CdgA and CdgH Do Not Form a Complex
It is proposed that the subcellular compartmentalization of c-di-
GMP signaling components might allow c-di-GMP to act locally
on specific cellular processes such as motility or biofilm formation
[5,35]. C-di-GMP signaling proteins could exert their effects by
participating in complexes that include signal producers (DGC),
removers (PDE), receptors, and/or targets [3,6]. To determine if
co-localization occurs between DGCs activating VpsT and the c-
di-GMP receptor, VpsT, we analyzed their subcellular localiza-
tion. We chose CdgA and CdgH, two DGCs that affect vps
expression (Figure 1D) and have demonstrated DGC activity
(Shikuma and Yildiz, unpublished data) [14]. To observe the
subcellular localization of CdgA and CdgH we constructed C-
terminal tagged CdgA-GFP and CdgH-GFP fusions. Both cdgA-gfp
and cdgH-gfp were able to complement in-frame deletions of cdgA
and cdgH, respectively (Figure S5), indicating that our fusion
proteins are functional. When observed by fluorescence micros-
copy, CdgA-GFP and CdgH-GFP both appeared to localize to the
Figure 1. VpsT Localization is Dependent on Multiple Digua-
nylate Cyclases. (A) The expression of a chromosomal vpsL promoter-
lacZ fusion was measured in wild type (Wt) or DvpsT strains containing
pBAD vector alone, or pBAD containing vpsT or gfp-vpsT using b-
galactosidase assays. One representative experiment of three biological
replicates is shown. Error bars indicate standard deviations of eight
technical replicates. (B) Representative epifluorescence micrographs are
shown of the subcellular localization of GFP or GFP-VpsT fusion protein
in wild-type or D5DGC V. cholerae strains. Marker is 2 mm. (C) Single-cell
quantification of subcellular fluorescence localization. The number of
spots per cell is shown as a histogram for wild type or D5DGC strains
expressing GFP or GFP-VpsT. Data are acquired from at least 3
independent experiments and quantification was performed on at least
150 cells per treatment. (D) Expression of the vpsL promoter fused to a
lux reporter operon in wild-type V. cholerae (Wt) or strains containing
single in-frame deletions of the genes encoding DGCs cdgA, cdgH, cdgK,
cdgL, cdgM or a strain containing in-frame deletions all 5 DGCs (D5DGC).
Expression is reported in luminescence counts min
21 ml
21/OD600 nm.
One representative experiment of three biological replicates is shown.
Error bars indicate standard deviations of four technical replicates. (E)
Percent c-di-GMP levels of single in-frame deletion DGC mutants or the
D5DGC strain compared to wild type V. cholerae using high-
performance liquid chromatography-tandem mass spectrometry. Error
bars indicate standard deviations of three biological replicates.
doi:10.1371/journal.ppat.1002719.g001
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CdgA and CdgH are predicted to contain 2 and 1 transmembrane
domains, respectively [36].
To corroborate these results, we performed cellular fraction-
ation and western blot analysis to identify the subcellular location
of VpsT, CdgA and CdgH. We therefore created strains
containing an N-terminal HA tagged vpsT, a C-terminal HA
tagged cdgA or a C-terminal HA tagged cdgH in their native
chromosomal loci. Strains containing each fusion protein exhib-
ited similar vpsL expression when compared to wild type (Figure
S5). Both CdgA-HA and CdgH-HA localized to the total
membrane fraction, as predicted (Figure 2B). In contrast, HA-
VpsT localized mostly to the cytoplasmic fraction, but a lower
level also consistently appeared in the total membrane fraction. To
determine whether VpsT localization is dependent on the
presence of specific DGCs or c-di-GMP levels, we performed a
cellular fractionation of wild-type and D5DGC strains and probed
for HA-VpsT levels. HA-VpsT localization was not different
between wild-type and D5DGC strains (Figure S6), suggesting that
the 5 DGCs or c-di-GMP levels are not important for the
localization of VpsT to specific cellular fractions.
Although VpsT resides mainly in a different subcellular region
of the cell when compared to CdgA or CdgH, it is possible that
transient interactions between these proteins contribute to
specificity in c-di-GMP signaling. To address whether VpsT can
interact with CdgA or CdgH directly, we performed a bacterial
two-hybrid analysis using a system suited to identify protein-
protein interactions, even under the condition where one or both
proteins are membrane bound [37]. Using bacterial two-hybrid
vectors, VpsT, CdgA and CdgH were fused to the T18 or T25
complementary fragments of Bordetella pertussis adenylate cyclase
(CyaA). Interaction between co-expressed proteins of interest in E.
coli reconstitute a functional CyaA, leading to cAMP production
[38]. As expected, a signal indicative of interaction of VpsT with
itself was observed by colorimetric blue production on LB agar
containing bromo-chloro-indolyl-galactopyranoside (X-gal), as
well as quantitatively using b-galactosidase assays (Figure 2C
and S7). Interaction of CdgA with itself and CdgH with itself was
also observed (Figure 2C and S7). These results were expected as
DGCs from other bacteria were shown previously to catalyze c-di-
GMP production as dimers [39,40]. Interestingly, E. coli contain-
ing CdgA and CdgH on complementary plasmids exhibited
increased b-galactosidase production, suggesting that these DGCs
might interact, however the physiological relevance of this
observation is unclear at this point. Importantly, strains expressing
both VpsT and CdgA or VpsT and CdgH did not exhibit
increased cAMP production, even when the reciprocal exchange
of fusion domains was performed (Figure 2C and S7). These
results suggest that VpsT does not interact directly with CdgA or
CdgH.
VpsT Requires c-di-GMP Binding for Subcellular
Localization and Activity
We next wondered whether VpsT localization is dependent on
specific domains and/or interfaces important for VpsT function.
Mutations in residues required for c-di-GMP binding (VpsT
R134A)
or c-di-GMP-stabilized dimerization (VpsT
I141E) were unable to
complement a DvpsT mutation (Figure 3A), consistent with our
previous findings [21]. When observed by fluorescence microsco-
py, both GFP-VpsT
R134A and GFP-VpsT
I141E mutants exhibited a
homogenous fluorescence throughout the cytoplasm, possessed
almost no spots per cell, and showed a significantly lower
maximum to average fluorescence intensity ratio when compared
to strains expressing a wild-type GFP-VpsT fusion (Figure 3B, 3C
Figure 2. VpsT Does Not Interact with CdgA or CdgH Directly.
(A) Representative epifluorescence micrographs of wild-type V. cholerae
expressing GFP-VpsT, CdgA-GFP or CdgH-GFP fusion proteins. Marker is
2 mm. (B) Subcellular fractionation of V. cholerae strains containing vpsT,
cdgA or cdgH tagged with an HA epitope in their native chromosomal
loci. Western immunoblot was performed on cellular fractions
representing whole cell (WC), cytoplasmic (C) and total membrane
(M) fractions. HA-tagged proteins were detected using a polyclonal
anti-HA antibody. gfp was constitutively expressed from a chromosomal
locus. GFP was detected using monoclonal anti-GFP antibody and is
used as a cytoplasmic fraction control. OmpU was detected using a
polyclonal anti-OmpU antibody and is used as a total membrane
fraction control. One representative experiment of three biological
replicates is shown. (C) Bacterial two-hybrid analysis of VpsT, CdgA and
CdgH. Reconstitution of CyaA, indicative of protein-protein interaction,
was detected by b-galactosidase activity on LB plates containing
ampicillin (100 mg/ml), kanamycin (50 mg/ml), IPTG (500 mM) and X-gal
(40 mg/ml). Plates were incubated at 30uC for 48 h.
doi:10.1371/journal.ppat.1002719.g002
A Mechanism of c-di-GMP Signaling in V. cholerae
PLoS Pathogens | www.plospathogens.org 4 May 2012 | Volume 8 | Issue 5 | e1002719and S8). VpsT contains a C-terminal helix-turn-helix (HTH) DNA
binding domain and H193 of VpsT aligned with other histidine
residues in the LuxR/FixJ superfamily shown previously to be
required for DNA binding (Figure S8) [41,42]. A strain harboring
GFP-VpsT
H193A was unable to induce vps expression (Figure 3A)
and appeared to localize to foci that were more dispersed
throughout the cell when compared to wild type GFP-VpsT
(Figure 3B). The number of spots per cell and the ratio of
maximum to average fluorescence intensity of the GFP-
VpsT
H193A expressing strain were decreased compared to wild-
type GFP-VpsT (Figure 3C and S8). Therefore, VpsT localization,
albeit different than that of the wild-type localization pattern, can
still occur in the absence of DNA binding. The subcellular
localization patterns were not due to differential protein levels, as
cellular concentrations of wild-type GFP-VpsT were similar to
GFP-VpsT with R134A, I141E or H193A point mutations (Figure
S8). Taken together, our results indicate that the wild-type VpsT
localization pattern is dependent on c-di-GMP binding and DNA
binding. These results suggest that VpsT forms oligomers on DNA
binding sites distributed on the V. cholerae chromosomes and the
localization pattern is due to binding of VpsT to its target
sequences on the genome.
VpsT Localization in a Heterologous Host Depends on
Cellular c-di-GMP Levels
To determine whether there are other factors responsible for
VpsT localization in V. cholerae, we expressed GFP-VpsT in E. coli.
GFP-VpsT was surprisingly homogenous throughout the cyto-
plasm when expressed in E. coli in contrast to the same construct
expressed in V. cholerae (data not shown), suggesting that the
localization of VpsT requires cellular components or a cellular
environment provided by the V. cholerae cell. We then hypothesized
that the localization of VpsT might either require increased levels
of c-di-GMP or specifically require a DGC important for biofilm
formation in V. cholerae. A compatible plasmid that expresses cdgA
from an IPTG inducible promoter was therefore introduced into
E. coli containing GFP-VpsT. Strains expressing CdgA showed a
marked decrease in motility when compared to strains containing
vector alone (Figure 4C), indicating that CdgA is functional as a
DGC in E. coli. When observed by fluorescence microscopy, GFP-
VpsT formed foci in the presence of CdgA in E. coli (Figure 4A).
This strain exhibited an increase in the number of spots per cell
and a significantly increased ratio of maximum to average
fluorescence intensity compared to a strain with GFP-VpsT and
an empty compatible plasmid (Figure 4A, 4B and S9). To
determine whether VpsT localization is dependent on the catalytic
activity of CdgA, we also expressed CdgA containing a point
mutation converting the conserved GGDEF motif to GADEF
(cdgA
G287A) in cells also expressing GFP or GFP-VpsT. Expression
of CdgA
G287A in E. coli was not able to recover VpsT localization,
in contrast to wild type CdgA (Figure 4A, 4B and S9).
Furthermore, the motility zone diameter of a strain expressing
CdgA
G287A was similar to that of a strain with vector alone
(Figure 4C). As expected, strains expressing GFP alone with the
same compatible plasmids showed no localization pattern
(Figure 4A, 4B and S9). These results suggest that the catalytic
activity of CdgA as a DGC is required for VpsT localization.
Figure 3. The Subcellular Localization of VpsT is Dependent on
c-di-GMP Binding and DNA Binding Residues. (A) The expression
of a chromosomal vpsL promoter-lacZ fusion was measured in wild type
(Wt) or DvpsT strains containing pBAD vector alone, or pBAD containing
gfp fused to wild type and mutated versions of vpsT using b-
galactosidase assays. A R134A mutation disrupts c-di-GMP binding
and an I141E mutation abolishes c-di-GMP-dependent dimerization.
H193A lies in the DNA binding domain of VpsT. (B) Subcellular
localization of GFP, GFP-VpsT or GFP-VpsT containing the indicated
point mutations, expressed in V. cholerae DvpsT. Representative
epifluorescence micrographs are shown. Marker is 2 mm. (C) Single-
cell quantification of subcellular fluorescence localization. The number
of spots per cell is shown as a histogram for DvpsT strains expressing
GFP, GFP-VpsT or GFP-VpsT containing the indicated point mutations.
Data are acquired from at least 3 independent experiments and
quantification was performed on at least 150 cells per treatment.
doi:10.1371/journal.ppat.1002719.g003
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cholerae is dependent on an intact DNA binding domain. To test
whether VpsT requires DNA binding in E. coli, we expressed GFP-
VpsT with a plasmid harboring the vpsL promoter (vpsLp).
However, this strain did not exhibit a VpsT localization pattern
(Figure 4A, 4B and S9). To determine whether VpsT requires both
CdgA and a native DNA binding region, we expressed GFP-VpsT
in cells containing a plasmid with both cdgA and the vpsL promoter.
In this strain, GFP-VpsT appeared to form a more discrete
pattern, exhibited an increased number of spots per cell, and a
higher maximum to average intensity ratio when compared to
GFP-VpsT cells co-expressing only CdgA (Figure 4A, 4B and S9).
E. coli co-expressing GFP alone with the same compatible plasmids
showed no localization pattern (Figure 4A, 4B and S9). To further
determine whether GFP-VpsT activity requires c-di-GMP in E.
coli, we quantified the expression of vpsL in the presence and
absence of CdgA. Only E. coli co-expressing GFP-VpsT and CdgA
activated vpsL expression while a strain expressing only GFP-VpsT
Figure 4. VpsT Localization in a Heterologous Host Depends on c-di-GMP. (A) Representative epifluorescence micrographs of E. coli strains
expressing GFP or GFP-VpsT and containing a pKNT25 compatible plasmid or pKNT25 harboring cdgA, cdgA
G287A, vpsL promoter (vpsLp), cdgA and
vpsLp or adrA from S. typhimurium. Marker is 2 mm. (B) Single-cell quantification of subcellular fluorescence localization. The number of spots per cell
is shown as a histogram for E. coli strains containing the indicated plasmids. Data are acquired from at least 3 independent experiments and
quantification was performed on at least 150 cells per treatment. (C) Representative motility phenotypes of E. coli expressing the indicated plasmids
grown on soft agar plates containing kanamycin and 10 mM IPTG at 37uC for 12 h.
doi:10.1371/journal.ppat.1002719.g004
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VpsT localization is enhanced by DNA binding and requires
elevated c-di-GMP levels to activate gene expression.
We then wondered whether CdgA, as a V. cholerae DGC, is
required for VpsT localization or if a heterologous DGC could
induce VpsT to localize. We therefore expressed adrA, a previously
characterized gene encoding a DGC from Salmonella typhimurium
[43], in strains also containing GFP or GFP-VpsT. Strains
expressing AdrA showed a marked decrease in motility (Figure 4C),
indicating that AdrA is functional in E. coli.I nE. coli, AdrA caused
GFP-VpsT to localize to foci, similar to foci induced by CdgA
(Figure 4A, 4B and S9). As expected, co-expression of GFP and
AdrA showed no localization. These results indicate that VpsT
localization depends on the cellular level of c-di-GMP, and not on
the presence of a specific V. cholerae DGC. Altogether, our results
suggest that a direct interaction is not required for c-di-GMP
signal transduction between DGCs and c-di-GMP receptors.
Recently, the subcellular localization of other c-di-GMP
receptors was found to be dependent on c-di-GMP binding. C-
di-GMP controls the subcellular localization of the PilZ domain
containing c-di-GMP receptor YcgR in E. coli, where interaction
of a YcgR-c-di-GMP complex with the flagellar motor leads to
decreased motility and counter-clockwise rotational bias [8–10].
Moreover, multiple DGCs were shown to contribute additively to
these motility phenotypes [8]. In Caulobacter crescentus, c-di-GMP
binding to a conserved I-site of PopA mediates the sequestration of
this protein to the cell pole, where PopA facilitates cell cycle
progression [44]. No single deletion of a GGDEF or EAL domain
containing protein was sufficient to alter PopA localization [44].
However, the combined activity of two DGCs, PleD and DgcB,
was shown to alter cell cycle dynamics [45]. The subcellular
localization of YcgR and PopA appears to be modulated by the
additive activity of multiple DGCs in combination, similar to our
findings with VpsT.
This study is the first account of the subcellular localization of a
c-di-GMP binding transcriptional regulator. Results presented
here suggest that adequate levels of c-di-GMP contributed by
multiple DGCs modulate VpsT activity and not a physical
interaction or compartmentalization of c-di-GMP signaling
components (Figure 6). This study identifies the requirements for
signal transduction, localization and activity of a c-di-GMP
receptor protein and furthers our understanding of the mecha-
nisms of second messenger signaling.
Materials and Methods
Bacterial Strains, Plasmids and Culture Conditions
The bacterial strains and plasmids used in this study are listed in
Table S1. In-frame deletion, chromosomal fusion and point
mutation strains were generated according to previously published
protocols [46]. All V. cholerae and E. coli strains were grown
aerobically, at 30uC and 37uC, respectively, unless otherwise
noted. Growth medium consisted of LB media (1% Tryptone,
0.5% Yeast Extract, 1% NaCl), pH 7.5. LB-agar and soft agar
plates contained 1.5% and 0.3% (wt/vol) granulated agar (Difco),
respectively. Concentrations of antibiotics used, where appropri-
ate, were as follows: ampicillin (100 mg/ml), rifampicin (100 mg/
ml), chloramphenicol (E. coli 20 mg/ml, V. cholerae 5 mg/ml),
kanamycin (50 mg/ml) and gentamicin (30 mg/ml).
Recombinant DNA Techniques
All strains were verified by PCR. Plasmid sequences were
verified by DNA sequencing by Sequetech Corporation (Mountain
View, CA). Primers used in the present study were purchased from
Bioneer Corporation (Alameda, CA) and sequences are available
upon request.
Fluorescence Microscopy and Quantification
V. cholerae cells harboring the indicated plasmid were grown
overnight (15 to 17 h) aerobically in LB medium supplemented
with ampicillin. Cells were then diluted 1:1000 in fresh LB
medium and grown aerobically for 2 h, at which point arabinose
was added at a final concentration of 0.05% and cells were
Figure 5. Co-expression of VpsT and CdgA Activates vpsL
Expression in E. coli. Expression of the vpsL promoter fused to a lux
reporter operon in E. coli expressing GFP or GFP-VpsT and harboring
pKNT vector alone or pKNT containing cdgA. Expression is reported in
luminescence counts min
21 ml
21/OD600 nm. One representative exper-
iment of three biological replicates is shown. Error bars indicate
standard deviations of four technical replicates.
doi:10.1371/journal.ppat.1002719.g005
Figure 6. Model of c-di-GMP Signal Transduction in V. cholerae.
Cellular c-di-GMP levels modulate VpsT oligomerization and subcellular
localization. The additive effect of 5 membrane-bound DGCs regulates
cellular c-di-GMP levels modulating VpsT oligomerization state,
localization and DNA binding. Cytoplasmic membrane (CM).
doi:10.1371/journal.ppat.1002719.g006
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(OD600 nm) of 0.2 to 0.4). E. coli cells containing the indicated
plasmid were grown overnight in LB medium containing 2%
glucose, kanamycin and ampicillin. Cells were then diluted 1:50 in
fresh LB medium containing 0.1% arabinose and 100 mM IPTG
and cells were harvested 3 h later. Cell culture was spotted onto
1% agarose pads prepared with phosphate-buffered saline (PBS),
pH 7.4. Images were acquired using a Zeiss Axiovert 200
microscope equipped with a 636 Plan-Apochromat objective
(numerical aperture, 1.4), and were recorded with a Cool-Snap
HQ2 camera (Photometrics). Images were minimally processed
using Adobe Photoshop 11.0 and ImageJNIH software. Microbe-
Tracker [25] was employed, using the alg4ecoli parameter to
identify cell outlines, the spotFinderZ tool to determine the
number of spots per cell and the intprofile tool to determine the
maximum and average fluorescence intensities of single cells. Data
were acquired from at least 3 independent experiments and
quantification was performed on at least 150 cells per treatment.
All statistics were calculated using Graphpad Prism 4.
Cellular Fractionation and Immunoblot
Overnight cultures were diluted 1:200, grown to an OD600 nm of
0.3 to 0.4, and diluted again 1:200. Cells were harvested at an
OD600 nm of 0.3 to 0.4 by centrifugation (10,0006 g) and
fractionation was carried out as described previously [47]. Protein
levels were quantified using a bicinchoninic acid (BCA) kit
(Thermo Fisher Scientific Inc.) and normalized between fractions.
Proteins were separated on a 12% SDS-polyacrylamide gel and
electroblotted onto a nitrocellulose membrane with a Mini Trans-
Blot Cell (Bio-Rad) as described previously [47]. Rabbit polyclonal
antiserum against V. cholerae OmpU (provided by K. Klose) was
used at a dilution of 1:100,000. Mouse monoclonal antibody
against GFP (Santa Cruz Biotechnology) and rabbit polyclonal
antibody against the HA epitope (Santa Cruz Biotechnology) were
used according to the manufacturer’s instructions. Horseradish
peroxidase-conjugated goat anti-rabbit secondary antibody (Santa
Cruz Biotechnology) or goat anti-mouse secondary antibody
(Santa Cruz Biotechnology) was used according to the manufac-
turer’s instructions. Immunoblot analyses were conducted with at
least three biological replicates.
b-galactosidase Assays
b-galactosidase assays were performed and Miller units calcu-
lated as described previously [48]. The assays were repeated with
three biological replicates and six technical replicates.
Luminescence Assays
V. cholerae or E. coli cells harboring the indicated plasmid were
grown overnight (15 to 17 h) aerobically in LB medium
supplemented with the appropriate antibiotics. Cells were then
diluted 1:1000 in fresh LB medium and harvested at exponential
phase at an OD600 nm of 0.3 to 0.4. E. coli were grown in the
presence of 0.1% arabinose and 100 mM IPTG for protein
expression. Luminescence was measured using a Victor3 Multi-
label Counter (PerkinElmer) and Lux expression is reported as
counts min
21 ml
21/OD600 nm. Assays were repeated with at least
three biological replicates and four technical replicates.
Quantification of Cellular c-di-GMP Levels
Cellular c-di-GMP levels were measured in the indicated strains
grown to exponential phase in LB medium. Protein concentration
was determined using a BCA kit according to the manufacturer’s
instructions. C-di-GMP extraction, analysis by high-performance
liquid chromatography-tandem mass spectrometry (HPLC-MS/
MS) and c-di-GMP standard curve generation were carried out as
described previously [26]. C-di-GMP quantification was per-
formed with at least three biological replicates.
Bacterial Two-hybrid Assay
Bacterial two-hybrid assays were performed as described
previously [38]. Translational fusions were created with proteins
of interest and T18 or T25 fragments of B. pertussis adenylate
cyclase (CyaA). All constructs were confirmed by DNA sequenc-
ing. Plasmids pKT25-zip and pUT18C-zip, each containing
translational fusions to the leucine zipper of GCN4, were used
as positive controls. Production of cAMP by reconstituted CyaA
was observed in the E. coli strain BTH101, lacking a native cyaA
gene. Protein-protein interactions were observed by growing cells
for 48 to 72 h at 30uC on LB agar containing ampicillin (100 mg/
ml), kanamycin (50 mg/ml), X-gal (40 mg/ml) and IPTG (10 to
500 mM), or quantified by performing b-galactosidase assays with
cells grown overnight at 30uC in LB medium containing ampicillin
(100 mg/ml), kanamycin (50 mg/ml) and IPTG (10 mM).
Accession Numbers
GenBank accession numbers are as follows: VpsT,
NP_233336.1; VpsL, NP_230581.1; CdgA, NP_232475.1; CdgH,
NP_230712.1; CdgK, NP_230749.1; CdgL, NP_231916.1;
CdgM, NP_231020.1; MbaA, NP_230352.1; RocS,
NP_230302.1; CdgC, NP_233171.1.
Supporting Information
Figure S1 Localization of GFP-VpsT in strains lackingc
genes encoding DGCs important for vps expression.
Localization of GFP-VpsT in wild-type V. cholerae (Wt), strains with
in-frame deletions of the genes encoding DGCs cdgA, cdgH, cdgK,
cdgL, cdgM or a strain where all 5 DGCs are deleted in
combination (D5DGC). Wild type expressing GFP is included as
a fluorescence localization control. (A) Representative epifluores-
cence micrographs of the indicated strains are shown. Marker is
2 mm. (B) The number of spots per cell is shown as a histogram for
the strains indicated. Data are acquired from at least 3
independent experiments and quantification was performed on
at least 150 cells per treatment. (C) The ratio of maximum to
average fluorescence intensity across the length of individual cells
is shown as box plots for the indicated strains. Upper quartile,
median and lower quartiles are indicated by top, middle and
bottom lines of boxes, respectively, largest and smallest observa-
tions are indicated by lines above and below boxes, circles are
outliers. Data are acquired from at least 3 independent
experiments and quantification was performed on at least 150
cells per treatment. *, p,0.0001 using a student’s t-test. (D)
Protein levels of GFP-VpsT relative to GFP alone in wild type and
D5DGC. Strains were grown in the same conditions as those used
for fluorescent subcellular localization as described in the materials
and methods. Equal amounts of protein from each sample were
separated on a SDS-polyacrylamide gel, electroblotted onto a
nitrocellulose membrane and detected using a monoclonal
antibody against GFP (Santa Cruz Biotechnology) and an HRP-
conjugated secondary antibody. Band intensities were quantified
using ImageQuant software (Molecular Dynamics). Data indicate
the average of at least three biological replicates and error bars
indicate standard error.
(TIF)
Figure S2 Census of vps expression in strains with
deletions in each gene encoding a GGDEF and/or EAL
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vpsL in 52 strains containing in-frame deletions of each gene in V.
cholerae genome encoding proteins containing GGDEF (A), EAL
(B) or GGDEF and EAL (C) domains. Expression of vpsL was
quantified using a vpsLp-lux operon transcriptional fusion on a
plasmid in wild-type V. cholerae (Wt) or strains containing in-frame
deletions of each gene indicated. Cells were grown to exponential
phase (OD600 nm of 0.3 to 0.4) in LB media containing
chloramphenicol (5 mg/ml). Expression is reported in lumines-
cence counts min
21 ml
21/OD600 nm. Error bars indicate standard
deviations of four technical replicates. One representative
experiment is shown of at least three biological replicates.
(TIF)
Figure S3 A single DGC can rescue vpsL expression in
the D5DGC strain. Expression of a chromosomal vpsL
promoter-lacZ fusion was measured in wild type (Wt) or D5DGC
V. cholerae strains containing pBAD vector alone, or pBAD
containing cdgA using b-galactosidase assays. One representative
experiment of three biological replicates is shown. Error bars
indicate standard deviations of eight technical replicates.
(TIF)
Figure S4 Localization of GFP-VpsT in strains lacking
genes encoding PDEs important for vps expression.
Localization of GFP-VpsT in wild-type V. cholerae (Wt), in-frame
deletion strains of the genes encoding PDEs cdgC, mbaA, rocS,o ra
strain where all 3 PDEs are deleted in combination (D3PDE). Wild
type expressing GFP is included as a fluorescence localization
control. (A) Representative epifluorescence micrographs are
shown. Marker is 2 mm. (B) The number of spots per cell is
shown as a histogram for the strains indicated. Data are acquired
from at least 3 independent experiments and quantification was
performed on at least 150 cells per treatment. (C) The ratio of
maximum to average fluorescence intensity across the length of
individual cells is shown as box plots for the indicated strains. Data
are acquired from at least 3 independent experiments and
quantification was performed on at least 150 cells per treatment.
(TIF)
Figure S5 Complementation with GFP-fusion or HA-
epitope tagged proteins. Relative expression, compared to
wild type (Wt), of a chromosomal vpsL promoter fusion to lacZ in
(A) wild type carrying pBAD vector or DcdgA strains carrying
pBAD vector or pBAD containing a cdgA-gfp fusion, or (B) wild
type carrying pBAD vector or DcdgH strains carrying pBAD vector
or pBAD containing a cdgH-gfp fusion. Cells were grown to
exponential phase (OD600 nm of 0.3 to 0.4) in LB broth containing
ampicillin (100 mg/ml) and arabinose (0.01 to 0.05%). Error bars
indicate standard deviation of at least 6 technical replicates. The
results shown are one representative experiment of three biological
replicates. Expression of a vpsL promoter fusion to a lux operon in
(C) wild type, DvpsT or chromosomal HA-vpsT strains, (D) wild
type, DcdgA or chromosomal cdgA-HA strains or (E) wild type,
DcdgH or chromosomal cdgH-HA strains. Error bars indicate
standard deviation of at least 4 technical replicates. The results
shown are one representative experiment of three biological
replicates.
(TIF)
Figure S6 The cellular localization of VpsT is not
altered in the D5DGC Strain. Subcellular fractionation of V.
cholerae wild type (Wt) or D5DGC strains containing vpsT tagged
with an HA epitope in the native vpsT locus. Western immunoblot
was performed on cellular fractions representing whole cell (WC),
cytoplasmic (C) and total membrane (M) fractions. HA-VpsT was
detected using a polyclonal anti-HA antibody. gfp was constitu-
tively expressed from a chromosomal locus. GFP was detected
using monoclonal anti-GFP antibody and is used as a cytoplasmic
fraction control. OmpU was detected using a polyclonal anti-
OmpU antibody and is used as a total membrane fraction control.
One representative experiment of three biological replicates is
shown.
(TIF)
Figure S7 VpsT does not interact directly with CdgA or
CdgH. vpsT was cloned into vectors pUT18C or pKT25 creating
plasmids expressing full length VpsT, tagged at its N-terminus with
T18 or T25 fragments of B. pertussis adenylate cyclase (cyaA). cdgA
or cdgH was cloned into vectors pUT18 or pKNT25, creating
proteins tagged at their C-termini with T18 or T25. Empty vectors
or those containing fusion proteins were co-transformed into E. coli
strain BTH101. Quantification of bacterial two-hybrid interac-
tions was performed by b-galactosidase assays on cells containing
the indicated plasmids grown overnight at 30uC in LB broth
containing ampicillin (100 mg/ml), kanamycin (50 mg/ml) and
IPTG (10 mM). pKT25-zip and pUT18C-zip contain genes
encoding the GCN4 leucine zipper as a positive protein-protein
interaction control.
(TIF)
Figure S8 Localization of GFP-VpsT point mutants. (A)
Single-cell quantification of GFP-VpsT subcellular localization.
The ratio of maximum to average fluorescence intensity across the
length of individual cells is shown as box plots for DvpsT strains
expressing GFP, GFP-VpsT or GFP-VpsT containing the
indicated point mutations. Data are acquired from at least 3
independent experiments and quantification was performed on at
least 150 cells per treatment. *, p,0.0001 using a student’s t-test.
(B) Protein levels of wild type and mutant GFP-VpsT fusion
proteins relative to GFP alone. Strains were grown in the same
conditions as those used for fluorescent subcellular localization as
described in the materials and methods. Equal amounts of protein
from each sample were separated on a SDS-polyacrylamide gel,
electroblotted onto a nitrocellulose membrane and detected using
a monoclonal antibody against GFP (Santa Cruz Biotechnology)
and an HRP-conjugated secondary antibody. Band intensities
were quantified using ImageQuant software (Molecular Dynam-
ics). Data indicate the average of at least three biological replicates
and error bars indicate standard error. (C) VpsT helix-turn-helix
sequence alignment. Sequence alignment, using ClustalW, of the
VpsT helix-turn-helix region with other members of the LuxR/
FixJ superfamily of transcription factors. Protein sequences used to
generate the alignment are as follows: Vibrio cholerae O1 El Tor
N16961 VpsT (NP_233336), Vibrio fischeri MJ11 LuxR
(YP_002158591), Escherichia coli O157:H7 NarL (NP_287469),
Sinorhizobium meliloti 1021 FixJ (NP_435915), Bacillus subtilis subsp.
subtilis str. 168 DegU (NP_391429). Numbers to the left of each
protein name correspond to the starting amino acid number of
each protein. Arrow indicates residue H193 of VpsT.
(TIF)
Figure S9 Subcellular localization of VpsT expressed in
E. coli. The ratio of maximum to average fluorescence intensity
across the length of individual cells is shown as box plots for strains
expressing GFP (open box) or GFP-VpsT (shaded box) and
containing pKNT25 or pKNT25 harboring cdgA, cdgA
G287A, the
vpsL promoter (vpsLp), cdgA and vpsLp or adrA. Data are acquired
from at least 3 independent experiments and quantification was
performed on at least 150 cells per treatment. *, p,0.0001 using a
student’s t-test.
(TIF)
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